Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanxing Zhang

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Scientific Reports|January 12, 2026
Non-invasive screening of alzheimer's disease via label-free tri-spectral retinal imagingZita Salajková, Gabriele Ciasca, Francesco Di Lorenzo, et al.
JAMA|August 7, 2025
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: The HOPE Randomized Clinical TrialYing Zhou, Yaode He, Bruce C V Campbell, et al.
JAMA|February 5, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke: The OPTION Randomized Clinical TrialGaoting Ma, Ran Mo, Yingting Zuo, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Scientific Reports|January 12, 2026
Non-invasive screening of alzheimer's disease via label-free tri-spectral retinal imagingZita Salajková, Gabriele Ciasca, Francesco Di Lorenzo, et al.
JAMA|August 7, 2025
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: The HOPE Randomized Clinical TrialYing Zhou, Yaode He, Bruce C V Campbell, et al.
JAMA|February 5, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke: The OPTION Randomized Clinical TrialGaoting Ma, Ran Mo, Yingting Zuo, et al.
Pageof 4